Although several factors, including male sex, tumor size, and certain biomarkers, showed significant associations with outcomes in the univariate analysis, only cancer stage and CD31 levels had a significant independent influence in the multivariate analysis, indicating their robust roles as predictors of patient outcomes. The gene discussed is PECAM1; the disease is cancer.